Castle Creek Arbitrage, LLC - ISIS PHARMACEUTICALS INC DEL ownership

Quarter-by-quarter ownership
Castle Creek Arbitrage, LLC ownership history of ISIS PHARMACEUTICALS INC DEL
ValueSharesWeighting
Q3 2021$150,000
-0.7%
150,0000.0%0.01%0.0%
Q2 2021$151,000
-1.3%
150,0000.0%0.01%
-11.1%
Q1 2021$153,000
-6.1%
150,0000.0%0.01%
-10.0%
Q4 2020$163,000
+4.5%
150,0000.0%0.01%
-16.7%
Q3 2020$156,000
-6.0%
150,0000.0%0.01%
-14.3%
Q2 2020$166,000
+8.5%
150,0000.0%0.01%
-44.0%
Q1 2020$153,000
-98.8%
150,000
-98.6%
0.02%
-99.2%
Q3 2019$12,253,000
-3.8%
10,734,0000.0%3.09%
-6.9%
Q2 2019$12,733,000
-12.3%
10,734,0000.0%3.32%
-22.2%
Q1 2019$14,515,000
+308.2%
10,734,000
+114.7%
4.27%
+1356.0%
Q2 2016$3,556,000
-22.1%
5,000,0000.0%0.29%
-19.9%
Q1 2016$4,564,0005,000,0000.37%
Other shareholders
ISIS PHARMACEUTICALS INC DEL shareholders Q4 2021
NameSharesValueWeighting ↓
TENOR CAPITAL MANAGEMENT Co., L.P. 74,881,000$76,559,0001.97%
III Capital Management 15,000,000$15,227,0001.82%
TFG Asset Management GP Ltd 14,055,000$14,321,0001.02%
MACKAY SHIELDS LLC 28,304,000$28,739,0000.21%
RWC Asset Management LLP 6,500,000$6,604,0000.20%
PALISADE CAPITAL MANAGEMENT, LP 7,187,000$7,281,0000.17%
CQS (US), LLC 4,000,000$4,092,0000.13%
FARALLON CAPITAL MANAGEMENT LLC 24,435,000$24,797,0000.12%
D. E. Shaw & Co., Inc. 59,728,000$60,845,0000.06%
BNP Paribas Asset Management Holding S.A. 7,000,000$7,133,0000.03%
View complete list of ISIS PHARMACEUTICALS INC DEL shareholders